APA (7th ed.) Citation

Shan, M., Bi, H., Sun, H., Li, Y., Li, Z., Wang, Z., . . . Li, X. (2025). PCDHGB7 inhibits the progression of triple‐negative breast cancer by suppressing XRCC5/MYC‐mediated ribosome biogenesis. Clinical & Translational Medicine, 15(9), 1. https://doi.org/10.1002/ctm2.70437

Chicago Style (17th ed.) Citation

Shan, Ming, et al. "PCDHGB7 Inhibits the Progression of Triple‐negative Breast Cancer by Suppressing XRCC5/MYC‐mediated Ribosome Biogenesis." Clinical & Translational Medicine 15, no. 9 (2025): 1. https://doi.org/10.1002/ctm2.70437.

MLA (9th ed.) Citation

Shan, Ming, et al. "PCDHGB7 Inhibits the Progression of Triple‐negative Breast Cancer by Suppressing XRCC5/MYC‐mediated Ribosome Biogenesis." Clinical & Translational Medicine, vol. 15, no. 9, 2025, p. 1, https://doi.org/10.1002/ctm2.70437.